Результаты поиска

[[Category:Norepinephrine–dopamine reuptake inhibitors]] ...

...ntan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors | journal = Journal of Medicinal Chemistry | volume = 49 | issue = 4 | page [[Category:Norepinephrine–dopamine reuptake inhibitors]] ...

...Diphenyl-Methyl-Piperidine</ref> which acts as a [[norepinephrine-dopamine reuptake inhibitor]] (NDRI).<ref name="Ferris RM 1979">{{cite journal | vauthors = F {{Monoamine reuptake inhibitors}} ...

...er-excitability and thyrotoxicosis or while treated with monoamine oxidase inhibitors.<ref name=reactivan/> ...effect. The main mechanism of action was instead inhibition of dopamine [[reuptake]]. Also unlike [[amphetamine]]s, fencamfamin does not inhibit the action of ...

...nidate acts as both a [[dopamine reuptake inhibitor]] and [[norepinephrine reuptake inhibitor]], meaning it effectively boosts the levels of the [[norepinephri ...verse DAT agonist instead of (or at least only secondarily) as a classical reuptake inhibitor (which could be called a "[[competitive antagonist]] at the DAT" ...

{{Monoamine reuptake inhibitors}} [[Category:Norepinephrine–dopamine reuptake inhibitors]] ...

[[Category:Norepinephrine–dopamine reuptake inhibitors]] ...

...ntan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors | journal = Journal of Medicinal Chemistry | volume = 49 | issue = 4 | page [[Category:Norepinephrine–dopamine reuptake inhibitors]] ...

Methylphenidate is a [[catecholamine]] reuptake inhibitor that indirectly increases catecholaminergic neurotransmission by {{Monoamine reuptake inhibitors}} ...

...sing agent|releasing agent]], and to a lesser extent as a [[norepinephrine reuptake inhibitor]].<ref name="pmid10371658" /><ref name="pmid17339521" /> ...the release of norepinephrine, and hence acts purely as a [[norepinephrine reuptake inhibitor]].<ref name="pmid3708219" /><ref name="pmid2698268" /><ref name=" ...

...ntan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors | journal = Journal of Medicinal Chemistry | volume = 49 | issue = 4 | page [[Category:Norepinephrine–dopamine reuptake inhibitors]] ...

| class = [[Norepinephrine–dopamine reuptake inhibitor|NDRI]] [[antidepressant]]s ...the cases of "incomplete response" to the first-line [[selective serotonin reuptake inhibitor]] (SSRI) antidepressant.<ref name="pmid27141292"/><ref name="pmid ...

...hich tends to be less significant than with [[Selective serotonin reuptake inhibitors|SSRIs]]<ref>{{cite journal | vauthors = Kennedy SH, Rizvi SJ | title = Agom Agomelatine is a substrate of [[CYP1A2]], [[CYP2C9]] and [[CYP2C19]]. Inhibitors of these enzymes, e.g. the SSRI antidepressant [[fluvoxamine]], reduce its ...

...[[Depression_(mood)|depression]] in the case of the [[Selective serotonin reuptake inhibitor|SSRI]] class, may occur after stopping the intake of any antidepr ...C, Cipriani A, Linde K | title = Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-contr ...